The present invention discloses that the binding of Arf with Dm2, important components of the p53 tumor suppressor pathway, results in specific domains of both proteins undergoing a dramatic transition from dynamically disordered conformations to amyloid-like structures comprised of anti-parallel .beta.-strands. The invention exploits this discovery by providing unique methods for identifying and/or designing compounds that mimic, inhibit and/or enhance the effect of Arf on Dm2. The present invention also provides specific peptides derived from the binding domains of Arf and Dm2 which co-assemble into supramolecular structures comprised of binary anti-parallel .beta.-strands. The disclosed peptides may represent structural prototypes for a broader class of peptides that is capable of assembly into supramolecular structures.

 
Web www.patentalert.com

< Methods and reagents for assaying protein kinase activity

< Recurrent gene fusions in prostate cancer

> Method for screening therapeutic agents for disuse muscular atrophy using interaction between selected proteins and a polyubiquitin chain

> Human E3.alpha. ubiquitin ligase family

~ 00601